火博网页版登录入口

【Significant Favorable News】Poly Pharmaceuticals contributes to the significant achievements of CDMO's innovative immunotherapy drugs, taking a step closer to full commercialization !

Hainan Poly Pharm.Co., Ltd in the 2024 DCAT Week

【​INVITATION】CPHI2023 Booth No. : 2P29 --POLY PHARM

Zhejiang Poly Pharmaceutical's Eye Drop Workshop Complies with Chinese, American, and European GMP Requirements - Open to Domestic and International CDMO/CMO Collaborations

Anhui Poly Pharmaceutical's Magnesium Hydroxide API Approved for Market, with a Yearly Production Capacity of Up to 200 Tons!